| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |